Home / Publication / Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

論文

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

Author(s): Faustino Torrico, Joaquim Gascon, Lourdes Ortiz, Cristina Alonso-Vega, María-Jesús Pinazo, Alejandro Schijman, Igor Almeida, Fabiana Alves, Nathalie Strub-Wourgaft, Isabela Ribeiro, E1224 Study Group

Year: 2018年1月15日

AUC（線形および対数線形）の計算

ブログ

Accumulation: What It Means and How to Calculate It

ブログ

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

ビデオ

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

ビデオ

Powered by Translations.com GlobalLink Web Software

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial

AUC（線形および対数線形）の計算

Accumulation: What It Means and How to Calculate It

Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at Certara

Bridging Strategy & Execution: Sophia Fong’s Approach to Drug Development

メルマガ登録

クイックアクセス

ソリューション

お問合せ